Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 6]
Pharmac Shares Update On Its Assessment Of Trikafta
Monday, 15 August 2022, 1:08 pm | PHARMAC
Pharmac has today published the latest record of advice from its Pharmacology and Therapeutics Advisory Committee (PTAC) and, for the first time, has published a summary of how Pharmac has assessed Trikafta. “Trikafta is a medicine we would like to ... More >>
Aotearoa Less Affected By Medicine Supply Issues Than Other Countries
Friday, 22 July 2022, 6:42 am | PHARMAC
22 July 2022 Te Pātaka Whaioranga - Pharmac’s work behind the scenes and unique arrangements with suppliers means Aotearoa has been less affected by ongoing supply disruptions than other countries. Currently there are 47 medicine supply issues notified ... More >>
Pharmac Widens Access For COVID 19 Antiviral Treatments
Thursday, 14 July 2022, 12:51 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac has confirmed today that it is further widening access to the three antiviral treatments it funds for treating early COVID-19 to more than 400,000 more New Zealanders if they get the virus. Pharmac funds nirmatrelvir ... More >>
Pharmac Considering Funding New Medicines For Lung Cancer
Wednesday, 6 July 2022, 12:33 pm | PHARMAC
Pharmac, the medicine funding agency for Aotearoa is seeking proposals from pharmaceutical suppliers for medicines that could treat New Zealanders with lung cancer. “Lung cancer is one of the most commonly diagnosed cancers in Aotearoa and it is the leading ... More >>
Accuretic Supply Issue, Almost 36,000 New Zealanders Taking The Blood Pressure Medicine Will Need To Change Treatments
Thursday, 30 June 2022, 5:46 am | PHARMAC
Pharmac has updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier Pfizer, will be disrupted due to the detection of a contaminant called nitrosamine. This is a global issue, with voluntary recalls ... More >>
Pharmac Widens Flu Vaccine Access To Increase Uptake
Monday, 27 June 2022, 7:29 am | PHARMAC
Pharmac today announced that it is permanently widening access to the annual funded flu vaccine to people with specific mental health conditions and or addiction issues, as well for children aged 3 to 12 years for the rest of the 2022 flu season. The ... More >>
Pharmac Announces First Round Of Medicine Funding Decisions Following $191m Pharmaceutical Budget Increase
Wednesday, 15 June 2022, 10:38 am | PHARMAC
Pharmac today announces the first round of changes to medicines funding following its $191 million pharmaceutical budget increase over the next two years. The first changes include funding blood and breast cancer medicines, widening funded access ... More >>
Pharmac Seeks Views On Access Criteria For COVID-19 Treatments
Tuesday, 14 June 2022, 3:48 pm | PHARMAC
Pharmac is seeking feedback on access criteria for two new COVID-19 treatments - tixagevimab with cilgavimab and sotrovimab. “Pharmac has only been able to secure limited volumes of COVID-19 treatments, so we are using access criteria to ensure ... More >>
Multiple Funding Proposals Being Considered By Pharmac
Thursday, 19 May 2022, 4:47 pm | PHARMAC
Pharmac has issued three consultations today on proposals to fund medicines for conditions including cancer, multiple sclerosis, hormone replacement and HIV. The treatments being considered are estimated to benefit thousands of New Zealanders ... More >>
Pharmac Will Use Biggest Budget Increase Ever To Fund More Medicines For More New Zealanders
Thursday, 19 May 2022, 2:25 pm | PHARMAC
Pharmac welcomes the $191 million increase to its pharmaceutical budget over the next two years. It is already working its way through the medicines options for investment (OFI) list, looking at what agreements it can now make with pharmaceutical suppliers. ... More >>
Pharmac Widens Access To Medicine For RSV
Monday, 16 May 2022, 10:16 am | PHARMAC
Pharmac has announced today that it will be funding the preventative treatment, palivizumab, for the next two seasons of respiratory syncytial virus (RSV) for young children with severe diseases who need to be ventilated and pēpi (babies) with a ... More >>
Access Criteria For Antiviral Treatments Widened As Molnupiravir Arrives In New Zealand
Thursday, 28 April 2022, 2:15 pm | PHARMAC
Pharmac is widening access to the antivirals to treat people with early COVID-19, after receiving feedback from our expert advisors and clinicians that the access criteria needed updating and to be streamlined. This comes in time for the arrival ... More >>
Pharmac Welcomes Analysis Into Cancer Medicines In Aotearoa
Thursday, 28 April 2022, 5:46 am | PHARMAC
Pharmac welcomes a new report released today by Te Aho o Te Kahu (the Cancer Control Agency) which analyses the access and efficacy of cancer medicines for solid tumours in adult patients in Aotearoa. The new analysis, Understanding the gap: an analysis ... More >>
8,700 More Pacific Peoples Need Treatment To Prevent Gout Each Year To Achieve Equity
Monday, 11 April 2022, 1:14 pm | PHARMAC
Pharmac has released the Pacific peoples health – Gout data insights report today. The report shows that, while the prevalence of gout in Pacific peoples continues to climb, access to preventive gout medicine remains inequitable. The latest insights ... More >>
Pfizer’s Oral COVID-19 Treatment Arrives In New Zealand
Thursday, 31 March 2022, 6:55 am | PHARMAC
The first shipment of Pfizer’s new oral antiviral treatment for COVID-19, Paxlovid, has arrived in New Zealand and will be available for those who need it from next week. “While vaccinations and booster shots are the best defence against COVID-19, ... More >>
Pharmac To Fund New Treatments For Lung And Ovarian Cancer
Wednesday, 16 March 2022, 12:03 pm | PHARMAC
Pharmac has confirmed today they are funding a bundle deal which will give New Zealanders more effective treatment options for lung cancer and ovarian cancer. The bundle deal also includes a new medicine for people with severe eosinophilic asthma. The bundle ... More >>
Pūahoaho: Clarity Around Pharmac’s Priority Lists
Wednesday, 9 March 2022, 9:02 am | PHARMAC
Pharmac has released up-to-date information about its priority lists, including a list of declined medicine applications as part of its ongoing commitment to transparency. “We want New Zealanders to know we have heard their concerns about a lack of transparency. ... More >>
Pharmac Proposes Widened Access To The Flu Vaccine For Māori And Pacific Peoples For 2022 Season
Tuesday, 8 March 2022, 11:22 am | PHARMAC
Pharmac is consulting on a proposal to widen access to the funded influenza vaccine to include Māori and Pacific peoples aged between 55 and 64 years of age for the 2022 influenza season. Read the consultation on widening access “We anticipate ... More >>
Pharmac Updates Access Criteria For Remdesivir
Friday, 4 March 2022, 1:56 pm | PHARMAC
Pharmac has heard from our expert advisors and clinicians treating people with COVID-19 that we need to make further changes to the temporary access criteria for remdesivir. “On Monday 28 February Pharmac temporarily widened access criteria to remdesivir ... More >>
Flu Vaccine Price Increase
Tuesday, 1 March 2022, 9:45 am | PHARMAC
Pharmac has confirmed that the purchase price of the annual influenza vaccine will increase by $2 a dose, the first increase since 2008. “The influenza vaccine has been supplied at $9 a dose for the last 14 years,” says Pharmac’s Director of ... More >>
